1. Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States;Chhatwal;Ann Intern Med,2015
2. Institute for Clinical and Economic Review. The comparative clinical effectiveness and value of simeprevir and sofosbuvir in the treatment of chronic hepatitis C infection. Available from: https://icer-review.org/wp-content/uploads/2016/02/CTAF_Hep_C_Apr14_final.pdf. [Accessed February 26, 2017].
3. The biggest bang for the buck or bigger bucks for the bang: the fallacy of the cost-effectiveness threshold;Birch;J Health Serv Res Policy,2006